Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Pituitary prolactin producing adenoma with ossification: A rare histological variant and review of literature
Neuropathology, 09/17/09
Ke C et al. – As a rare histological variant of pituitary adenoma, the current case of pituitary prolactin producing adenoma with ossification is reported. It is speculated that the ossification may be derived from the osteo–metaplasia of mesenchymal fibroblasts resulting from the effects of both secondary ischemia by the outgrowth of the tumor and/or the autocrine effect of prolactin in this case. The bony shell structure may limit the growth of pituitary adenoma.
Related Articles
Signalling Pathway Alterations in Pituitary Adenomas: Involvement of Gsalpha, cAMP and Mitogen-Activated Protein Kinases
Journal of Neuroendocrinology, 11/03/09
Relevance Score: 68%
Regulation of Pituitary Function by Cytokines
Hormone Research, 10/27/09
Relevance Score: 67%
Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer
Pituitary, 10/29/09
Relevance Score: 66%
Pituitary metastasis of Merkel cell carcinoma
Journal of Neuro-Oncology, 10/28/09
Relevance Score: 66%
Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Journal of Clinical Endocrinology and Metabolism, 10/15/09
Relevance Score: 66%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines
Neuroendocrinology, 11/24/09
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiosurgery and whole brain therapy in the treatment of brainstem metastases
Clinical and Translational Oncology, 11/25/09
Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: A phase II study
Neurosurgery, 11/25/09
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


